<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font9" size="8" family="GillSans" color="#000000"/>
<text top="41" left="55" width="48" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>CytoJournal</i></text>
<text top="41" left="103" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2006, </text>
<text top="41" left="131" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="136" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:18</text>
<text top="41" left="387" width="167" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.cytojournal.com/content/3/1/18</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="142" segment_no="12" tag_type="text">Page 3 of 8</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="143" segment_no="13" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="34" segment_no="6" tag_type="text">perature. Slides were counterstained with hematoxylin,</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="35" segment_no="6" tag_type="text">dehydrated, and mounted for microscopical examination.</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="36" segment_no="6" tag_type="text">Optimization of conditions was performed with sections</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="37" segment_no="6" tag_type="text">of normal colon (hTERT-positive at the<a href=""> base [13] o</a>f the</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="38" segment_no="6" tag_type="text">crypts) (Figure <a href="">1A) and tissue</a> bladder biopsies with</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="39" segment_no="6" tag_type="text">urothelial carcinoma (Fig<a href="">ure 1B). N</a>egative control slides</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="40" segment_no="6" tag_type="text">included a blank control and omission of primary anti-</text>
<text top="333" left="55" width="24" height="9" font="font4" id="p1_t15" reading_order_no="41" segment_no="6" tag_type="text">body.</text>
<text top="357" left="55" width="158" height="9" font="font5" id="p1_t16" reading_order_no="42" segment_no="7" tag_type="title"><i><b>Assessment of hTERT immunostaining</b></i></text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="43" segment_no="8" tag_type="text">The entire hTERT stained slide was examined for immu-</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="44" segment_no="8" tag_type="text">nostaining of hTERT. Positivity for hTERT expression was</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="45" segment_no="8" tag_type="text">evaluated by two independent observers (WK, SG). Nucle-</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="46" segment_no="8" tag_type="text">olar urothelial cell positivity was used for evaluation of</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="47" segment_no="8" tag_type="text">utility in diagnosis. Positivity in non-urothelial cells such</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="48" segment_no="8" tag_type="text">as inflammatory cells, lymphocytes, microorganisms, or</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="49" segment_no="8" tag_type="text">contaminating debris was duly noted and recorded. The</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="50" segment_no="8" tag_type="text">availability of corresponding tissue bladder biopsy mate-</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="51" segment_no="8" tag_type="text">rial, which is the gold standard for diagnosis or exclusion</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="52" segment_no="8" tag_type="text">of urothelial carcinoma, enabled the determination of the</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="53" segment_no="8" tag_type="text">sensitivity and specificity of hTERT immunostaining for</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="54" segment_no="8" tag_type="text">the detection of bladder cancer. The positive and negative</text>
<text top="510" left="55" width="195" height="9" font="font4" id="p1_t29" reading_order_no="55" segment_no="8" tag_type="text">predictive values were determined as follows: </text>
<text top="510" left="250" width="46" height="9" font="font6" id="p1_t30" reading_order_no="56" segment_no="8" tag_type="text"><i>positive pre-</i></text>
<text top="521" left="55" width="28" height="9" font="font6" id="p1_t31" reading_order_no="57" segment_no="8" tag_type="text"><i>dictive </i></text>
<text top="521" left="83" width="213" height="9" font="font4" id="p1_t32" reading_order_no="58" segment_no="8" tag_type="text">value is equal to the number of truly positive cases</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="59" segment_no="8" tag_type="text">identified/total number of cases that tested positive ×</text>
<text top="545" left="55" width="30" height="9" font="font4" id="p1_t34" reading_order_no="60" segment_no="8" tag_type="text">100%, </text>
<text top="545" left="86" width="100" height="9" font="font6" id="p1_t35" reading_order_no="61" segment_no="8" tag_type="text"><i>negative predictive value </i></text>
<text top="545" left="186" width="110" height="9" font="font4" id="p1_t36" reading_order_no="62" segment_no="8" tag_type="text">is equal to the number of</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="63" segment_no="8" tag_type="text">truly negative cases identified/total number of cases that</text>
<text top="568" left="55" width="100" height="9" font="font4" id="p1_t38" reading_order_no="64" segment_no="8" tag_type="text">tested negative × 100%.</text>
<text top="87" left="313" width="36" height="10" font="font7" id="p1_t39" reading_order_no="88" segment_no="2" tag_type="title"><b>Results</b></text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="89" segment_no="4" tag_type="text">Optimization of the hTERT immunostaining technique,</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="90" segment_no="4" tag_type="text">as described in Materials and Methods, revealed that spe-</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="91" segment_no="4" tag_type="text">cific hTERT expression was nucleolar in both prolifera-</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="92" segment_no="4" tag_type="text">tively active normal cells, and in tumor cells. In normal</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="93" segment_no="4" tag_type="text">colon crypts, staining intensity was concentrated in the</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="94" segment_no="4" tag_type="text">base of the crypt (Figur<a href="">e 1A), as pr</a>eviously obs<a href="">erved [13</a>],</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="95" segment_no="4" tag_type="text">where the basal cells with proliferative capacity reside. In</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="96" segment_no="4" tag_type="text">excised bladder tumor tissue, the expression of hTERT was</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="97" segment_no="4" tag_type="text">clearly evident in the multiple nucleoli of neoplastic cells</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="98" segment_no="4" tag_type="text">(Figure <a href="">1B). Nota</a>bly, some morphologically normal</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="99" segment_no="4" tag_type="text">urothelia adjacent to the tumor border also expressed</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="100" segment_no="4" tag_type="text">hTERT, but the immunoreactivity diminished and was</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="101" segment_no="4" tag_type="text">lost in normal cells more distal to the tumor (Figure<a href=""> 1B</a>).</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="102" segment_no="4" tag_type="text">Diffuse nuclear staining accompanied nucleolar positivity</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="103" segment_no="4" tag_type="text">in a few examples, but we did not observe any cytoplasmic</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="104" segment_no="4" tag_type="text">staining. Lymphocytes were reactive to hTERT antibody,</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="105" segment_no="4" tag_type="text">as were yeast when presen<a href="">t (Figure 1C). Yeas</a>t is a com-</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="106" segment_no="4" tag_type="text">mon contaminant in clinical urine sampling and is</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="107" segment_no="4" tag_type="text">known to contain the telomerase enzyme, so the presence</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="108" segment_no="4" tag_type="text">of yeast can pose a serious confounding problem in urine-</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="109" segment_no="4" tag_type="text">based assays. Using the advantage of histological identifi-</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="110" segment_no="4" tag_type="text">cation facilitated using a hematoxylin counterstain, we</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="111" segment_no="4" tag_type="text">classified patient samples as positive when the presence of</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="112" segment_no="4" tag_type="text">specific nucleolar staining was evident in urothelial cells.</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="113" segment_no="4" tag_type="text">Patient demographics and tumor characteristics of the</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="114" segment_no="4" tag_type="text">samples evaluated are presented in Table<a href=""> 1.</a> The 101 cases</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="115" segment_no="4" tag_type="text">came from 53 male patients and 48 female patients. The</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="116" segment_no="4" tag_type="text">average age of the patients were 62 years (ranges: 30–91</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="117" segment_no="4" tag_type="text">years). The majority of the specimens were voided urine</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="118" segment_no="4" tag_type="text">specimens (61.4%). The majority of the urothelial carci-</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="119" segment_no="4" tag_type="text">noma cases were grade III (13 cases) and grade II (8 cases),</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="120" segment_no="4" tag_type="text">and one case grade I. The 39 non-malignant cases</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="121" segment_no="4" tag_type="text">included diagnoses of urolithiasis, cystitis glandularis and</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="122" segment_no="4" tag_type="text">cases with no detectable lesion. We also evaluated 33</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="123" segment_no="4" tag_type="text">cases classified as atypical by cytological examination. Tis-</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="124" segment_no="4" tag_type="text">sue bladder biopsies were available in 56 cases for histo-</text>
<text top="521" left="313" width="145" height="9" font="font4" id="p1_t76" reading_order_no="125" segment_no="4" tag_type="text">logical and cytological correlation.</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="126" segment_no="9" tag_type="text">All types of urothelial cancer expressed hTERT, including</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="127" segment_no="9" tag_type="text">transitional cell carcinomas of low grade, high grade, car-</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="128" segment_no="9" tag_type="text">cinoma in situ (CIS), squamous cell carcinoma (Figures</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="129" segment_no="9" tag_type="text"><a href="">1D–1</a>G), small cell carcinoma and metastatic adenocarci-</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="130" segment_no="9" tag_type="text">noma. Of the 29 cases cytologically diagnosed as malig-</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="131" segment_no="9" tag_type="text">nant and confirmed by biopsy, 27 (93%) exhibited</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="132" segment_no="9" tag_type="text">nucleolar hTERT expression (Table <a href="">2). One</a> case of high-</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="133" segment_no="9" tag_type="text">grade urothelial carcinoma and one case of squamous cell</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="134" segment_no="9" tag_type="text">carcinoma did not display hTERT expression. Among the</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="135" segment_no="9" tag_type="text">cytologically classified non-malignant cases, transitional</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="136" segment_no="9" tag_type="text">cell hTERT expression was detectable in only 3 (&lt;1%) of</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="137" segment_no="9" tag_type="text">the 39 samples evaluated. One of the 3 false-positive cases</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="138" segment_no="9" tag_type="text">was from a patient with confirmed diagnosis of urolithia-</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="139" segment_no="9" tag_type="text">sis (Figure <a href="">1J). </a>The other 2 cases have no corroborative</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="140" segment_no="9" tag_type="text">evidence of bladder disease to date. There were 56 cases</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="141" segment_no="9" tag_type="text">(malignant, benign and atypical cytologically) on which</text>
<text top="611" left="55" width="218" height="7" font="font8" id="p1_t93" reading_order_no="65" segment_no="10" tag_type="title"><b>Table 2: Comparison of hTERT immunoassay results with </b></text>
<text top="621" left="55" width="78" height="7" font="font8" id="p1_t94" reading_order_no="66" segment_no="10" tag_type="title"><b>cytological diagnosis.</b></text>
<text top="639" left="200" width="23" height="7" font="font9" id="p1_t95" reading_order_no="67" segment_no="11" tag_type="table">hTERT</text>
<text top="661" left="74" width="69" height="7" font="font9" id="p1_t96" reading_order_no="68" segment_no="11" tag_type="table">Cytological diagnosis</text>
<text top="661" left="173" width="26" height="7" font="font9" id="p1_t97" reading_order_no="69" segment_no="11" tag_type="table">Positive</text>
<text top="661" left="220" width="30" height="7" font="font9" id="p1_t98" reading_order_no="70" segment_no="11" tag_type="table">Negative</text>
<text top="661" left="270" width="18" height="7" font="font9" id="p1_t99" reading_order_no="71" segment_no="11" tag_type="table">Total</text>
<text top="683" left="59" width="26" height="7" font="font9" id="p1_t100" reading_order_no="72" segment_no="11" tag_type="table">Positive</text>
<text top="683" left="181" width="8" height="7" font="font9" id="p1_t101" reading_order_no="73" segment_no="11" tag_type="table">27</text>
<text top="683" left="233" width="4" height="7" font="font9" id="p1_t102" reading_order_no="74" segment_no="11" tag_type="table">2</text>
<text top="683" left="275" width="8" height="7" font="font9" id="p1_t103" reading_order_no="75" segment_no="11" tag_type="table">29</text>
<text top="694" left="59" width="29" height="7" font="font9" id="p1_t104" reading_order_no="76" segment_no="11" tag_type="table">Negative</text>
<text top="694" left="183" width="4" height="7" font="font9" id="p1_t105" reading_order_no="77" segment_no="11" tag_type="table">3</text>
<text top="694" left="231" width="8" height="7" font="font9" id="p1_t106" reading_order_no="78" segment_no="11" tag_type="table">36</text>
<text top="694" left="275" width="8" height="7" font="font9" id="p1_t107" reading_order_no="79" segment_no="11" tag_type="table">39</text>
<text top="704" left="59" width="27" height="7" font="font9" id="p1_t108" reading_order_no="80" segment_no="11" tag_type="table">Atypical</text>
<text top="704" left="181" width="8" height="7" font="font9" id="p1_t109" reading_order_no="81" segment_no="11" tag_type="table">19</text>
<text top="704" left="231" width="8" height="7" font="font9" id="p1_t110" reading_order_no="82" segment_no="11" tag_type="table">14</text>
<text top="704" left="275" width="8" height="7" font="font9" id="p1_t111" reading_order_no="83" segment_no="11" tag_type="table">33</text>
<text top="714" left="59" width="18" height="7" font="font9" id="p1_t112" reading_order_no="84" segment_no="11" tag_type="table">Total</text>
<text top="714" left="181" width="8" height="7" font="font9" id="p1_t113" reading_order_no="85" segment_no="11" tag_type="table">49</text>
<text top="714" left="231" width="8" height="7" font="font9" id="p1_t114" reading_order_no="86" segment_no="11" tag_type="table">52</text>
<text top="714" left="273" width="12" height="7" font="font9" id="p1_t115" reading_order_no="87" segment_no="11" tag_type="table">101</text>
<text top="87" left="55" width="213" height="7" font="font8" id="p1_t116" reading_order_no="5" segment_no="3" tag_type="title"><b>Table 1: Characteristics of cases evaluated in the hTERT </b></text>
<text top="96" left="55" width="51" height="7" font="font8" id="p1_t117" reading_order_no="6" segment_no="3" tag_type="title"><b>immunoassay</b></text>
<text top="114" left="59" width="12" height="7" font="font9" id="p1_t118" reading_order_no="7" segment_no="5" tag_type="table">Sex</text>
<text top="114" left="88" width="13" height="7" font="font9" id="p1_t119" reading_order_no="8" segment_no="5" tag_type="table">M/F</text>
<text top="114" left="221" width="19" height="7" font="font9" id="p1_t120" reading_order_no="9" segment_no="5" tag_type="table">53/48</text>
<text top="137" left="59" width="80" height="7" font="font9" id="p1_t121" reading_order_no="10" segment_no="5" tag_type="table">Voided urine specimens</text>
<text top="137" left="221" width="8" height="7" font="font9" id="p1_t122" reading_order_no="11" segment_no="5" tag_type="table">62</text>
<text top="137" left="260" width="20" height="7" font="font9" id="p1_t123" reading_order_no="12" segment_no="5" tag_type="table">61.4%</text>
<text top="147" left="59" width="81" height="7" font="font9" id="p1_t124" reading_order_no="13" segment_no="5" tag_type="table">Instrumented specimens</text>
<text top="147" left="221" width="8" height="7" font="font9" id="p1_t125" reading_order_no="14" segment_no="5" tag_type="table">39</text>
<text top="147" left="260" width="20" height="7" font="font9" id="p1_t126" reading_order_no="15" segment_no="5" tag_type="table">38.6%</text>
<text top="157" left="59" width="76" height="7" font="font9" id="p1_t127" reading_order_no="16" segment_no="5" tag_type="table">Positive for malignancy</text>
<text top="157" left="221" width="8" height="7" font="font9" id="p1_t128" reading_order_no="17" segment_no="5" tag_type="table">29</text>
<text top="157" left="260" width="20" height="7" font="font9" id="p1_t129" reading_order_no="18" segment_no="5" tag_type="table">28.7%</text>
<text top="167" left="88" width="70" height="7" font="font9" id="p1_t130" reading_order_no="19" segment_no="5" tag_type="table">Urothelial carcinoma</text>
<text top="167" left="221" width="8" height="7" font="font9" id="p1_t131" reading_order_no="20" segment_no="5" tag_type="table">25</text>
<text top="178" left="88" width="84" height="7" font="font9" id="p1_t132" reading_order_no="21" segment_no="5" tag_type="table">Squamous cell carcinoma</text>
<text top="178" left="221" width="4" height="7" font="font9" id="p1_t133" reading_order_no="22" segment_no="5" tag_type="table">3</text>
<text top="188" left="88" width="67" height="7" font="font9" id="p1_t134" reading_order_no="23" segment_no="5" tag_type="table">Small cell carcinoma</text>
<text top="188" left="221" width="4" height="7" font="font9" id="p1_t135" reading_order_no="24" segment_no="5" tag_type="table">1</text>
<text top="198" left="59" width="80" height="7" font="font9" id="p1_t136" reading_order_no="25" segment_no="5" tag_type="table">Negative for malignancy</text>
<text top="198" left="221" width="8" height="7" font="font9" id="p1_t137" reading_order_no="26" segment_no="5" tag_type="table">39</text>
<text top="198" left="260" width="20" height="7" font="font9" id="p1_t138" reading_order_no="27" segment_no="5" tag_type="table">38.6%</text>
<text top="208" left="59" width="76" height="7" font="font9" id="p1_t139" reading_order_no="28" segment_no="5" tag_type="table">Atypical/undetermined</text>
<text top="208" left="221" width="8" height="7" font="font9" id="p1_t140" reading_order_no="29" segment_no="5" tag_type="table">33</text>
<text top="208" left="260" width="20" height="7" font="font9" id="p1_t141" reading_order_no="30" segment_no="5" tag_type="table">32.7%</text>
<text top="219" left="59" width="91" height="7" font="font9" id="p1_t142" reading_order_no="31" segment_no="5" tag_type="table">Biopsy correlation available</text>
<text top="219" left="221" width="8" height="7" font="font9" id="p1_t143" reading_order_no="32" segment_no="5" tag_type="table">56</text>
<text top="219" left="260" width="20" height="7" font="font9" id="p1_t144" reading_order_no="33" segment_no="5" tag_type="table">55.5%</text>
</page>
</pdf2xml>
